Kazuyasu Miyoshi

1.7k total citations · 1 hit paper
16 papers, 927 citations indexed

About

Kazuyasu Miyoshi is a scholar working on Infectious Diseases, Surgery and Pharmacology. According to data from OpenAlex, Kazuyasu Miyoshi has authored 16 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 2 papers in Surgery and 2 papers in Pharmacology. Recurrent topics in Kazuyasu Miyoshi's work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 detection and testing (4 papers). Kazuyasu Miyoshi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 detection and testing (4 papers). Kazuyasu Miyoshi collaborates with scholars based in Japan. Kazuyasu Miyoshi's co-authors include Kazuo Imai, Toshimitsu Ito, Kaku Tamura, Sakiko Tabata, Satoshi Mimura, Satoshi Kishigami, Tadaki Suzuki, Toong Seng Tan, Kaori Sano and Takamasa Ueno and has published in prestigious journals such as Nature Communications, Journal of Clinical Microbiology and The Lancet Infectious Diseases.

In The Last Decade

Kazuyasu Miyoshi

15 papers receiving 915 citations

Hit Papers

SARS-CoV-2 D614G spike mutation increases entry efficienc... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuyasu Miyoshi Japan 7 783 208 186 129 111 16 927
Zijiao Zou China 9 713 0.9× 183 0.9× 210 1.1× 146 1.1× 63 0.6× 11 945
Anthony Chin‐Ki Ng Hong Kong 9 1.1k 1.4× 182 0.9× 241 1.3× 187 1.4× 120 1.1× 11 1.3k
Owen Tak‐Yin Tsang Hong Kong 11 768 1.0× 167 0.8× 230 1.2× 156 1.2× 81 0.7× 25 1.0k
Kit‐Hang Leung China 7 786 1.0× 142 0.7× 224 1.2× 150 1.2× 64 0.6× 13 985
Sebastian Hoehl Germany 15 975 1.2× 189 0.9× 213 1.1× 91 0.7× 100 0.9× 33 1.2k
Tommy Hing‐Cheung Tang China 8 644 0.8× 144 0.7× 189 1.0× 132 1.0× 61 0.5× 22 949
Pavithra Krishnan Hong Kong 8 915 1.2× 235 1.1× 289 1.6× 173 1.3× 59 0.5× 12 1.1k
Daisy Y.M. Ng Hong Kong 8 901 1.2× 232 1.1× 289 1.6× 173 1.3× 58 0.5× 13 1.1k
Xiao-Shuang Zheng China 6 1.1k 1.4× 103 0.5× 182 1.0× 179 1.4× 207 1.9× 8 1.4k

Countries citing papers authored by Kazuyasu Miyoshi

Since Specialization
Citations

This map shows the geographic impact of Kazuyasu Miyoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuyasu Miyoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuyasu Miyoshi more than expected).

Fields of papers citing papers by Kazuyasu Miyoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuyasu Miyoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuyasu Miyoshi. The network helps show where Kazuyasu Miyoshi may publish in the future.

Co-authorship network of co-authors of Kazuyasu Miyoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuyasu Miyoshi. A scholar is included among the top collaborators of Kazuyasu Miyoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuyasu Miyoshi. Kazuyasu Miyoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Imai, Kazuo, Katsumi Kubota, Yutaro Kitagawa, et al.. (2021). Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan. Journal of Medical Microbiology. 70(4). 4 indexed citations
2.
Ozono, Seiya, Yanzhao Zhang, Hirotaka Ode, et al.. (2021). SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity. Nature Communications. 12(1). 848–848. 310 indexed citations breakdown →
3.
Imai, Kazuo, Masaru Matsuoka, Sakiko Tabata, et al.. (2021). Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities. International Journal of Infectious Diseases. 111. 68–75. 11 indexed citations
4.
Imai, Kazuo, Yutaro Kitagawa, Sakiko Tabata, et al.. (2021). Antibody response patterns in COVID‐19 patients with different levels of disease severity in Japan. Journal of Medical Virology. 93(5). 3211–3218. 41 indexed citations
5.
Tabata, Sakiko, Kazuo Imai, Shuichi Kawano, et al.. (2020). Non-Severe vs Severe Symptomatic COVID-19: 104 Cases from the Outbreak on the Cruise Ship 'Diamond Princess' in Japan. SSRN Electronic Journal. 11 indexed citations
6.
Imai, Kazuo, Sakiko Tabata, Mayu Ikeda, et al.. (2020). Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19. Journal of Clinical Virology. 128. 104393–104393. 82 indexed citations
7.
Tabata, Sakiko, Kazuo Imai, Shuichi Kawano, et al.. (2020). Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis. The Lancet Infectious Diseases. 20(9). 1043–1050. 170 indexed citations
9.
Hase, Ryota, et al.. (2018). Legionella pneumonia appeared during hospitalization in a patient with hematological malignancy confirmed by sputum culture after negative urine antigen test. Journal of Infection and Chemotherapy. 24(7). 579–582. 2 indexed citations
10.
Miyoshi, Kazuyasu, Ryota Hase, Akihiko Shimizu, et al.. (2017). A Group G Streptococcal Bacteremia Case Series and Comparison of Community and Nosocomial Infections. Kansenshogaku zasshi. 91(4). 553–557.
11.
Miyoshi, Kazuyasu, et al.. (2015). The Great Imitator ; Clavicular Tuberculosis Mimics a Metastatic Neoplasm. Kansenshogaku zasshi. 89(5). 588–591. 4 indexed citations
12.
Hase, Ryota, Shunsuke Uno, Kazuyasu Miyoshi, et al.. (2015). Outpatient Parenteral Antimicrobial Therapy (OPAT) with Elastomeric Pumps in Collaboration with Home-visit Nursing Services in Japan : Experience of the First 10 Patients. Kansenshogaku zasshi. 89(5). 567–573. 4 indexed citations
13.
Hase, Ryota, Naoto Hosokawa, Daisuke Suzuki, et al.. (2014). 748Outpatient Parenteral Antimicrobial Therapy (OPAT) with Continuous Infusions by Elastomeric Infusion Devices in Japan, as an Effective Tool for Better Antimicrobial Stewardship. Open Forum Infectious Diseases. 1(suppl_1). S211–S211. 1 indexed citations
14.
Miyoshi, Kazuyasu, Hiroaki Fujita, Hitoshi Shinjo, et al.. (1995). Epidemiological Study of the Prognosis and Relevant Factors of Demented Patients.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 32(10). 656–663. 2 indexed citations
15.
Nomura, Akihiro, et al.. (1982). [Reproduction study on netilmicin. (1) Teratological study in rats (author's transl)].. PubMed. 35(2). 614–29. 1 indexed citations
16.
Miyoshi, Kazuyasu, et al.. (1972). [Cefazolin. 2. Primary clinical trial by oral administration].. PubMed. 25(1). 28–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026